Abstract
Humira® has been the top selling pharmaceutical since 2014. As a former Humira® user, for the treatment of Crohn’s disease, I explore how we understand the concept and experience of chronicity as it is represented in advertisements for Humira® and manifested in embodied reactions to these advertisements. Through a layered narrative method that combines rhetorical analysis with autoethnography, I analyze 13 Humira® commercials. I argue that Humira® commercials operate through a curative imaginary (Kafer, 2013), which not only assumes viewers desire to be immune-typical but also defines normative orientations to time. This case study reveals how direct-to-consumer pharmaceutical advertising obscures cultural and systemic sources of (dis)ablism, including the ways striving for normalcy is in and of itself an experience of chronicity, and disregards experiences of chronicity that disrupt normalizing boundaries of time.
- Journal
- Rhetoric of Health and Medicine
- Published
- 2022-06-01
- DOI
- 10.5744/rhm.2022.5011
- CompPile
- Search in CompPile ↗
- Topics
Citation Context
Cited by in this index (0)
No articles in this index cite this work.
Cites in this index (0)
No references match articles in this index.
Related Articles
-
Journal of Technical Writing and Communication Mar 2026“It's Hard to Show ROI When You’re Preventing Things from Happening”: How Impact Storytelling Frames Community Health Initiatives for Executive Audiences ↗Margaret Hsiao
-
Business and Professional Communication Quarterly Mar 2026Lauri Tapio Louekari
-
Computers and Composition Mar 2026Chinese EFL learners’ engagement with ChatGPT feedback on academic writing: A case study in Malaysia ↗Zhang Kailin; Murad Abdu Saeed
-
Business and Professional Communication Quarterly Feb 2026Apoorva Bharadwaj
-
Written Communication Feb 2026Zhaozhe Wang